Literature DB >> 2563854

Endogenous benzodiazepines in hepatic encephalopathy.

M Olasmaa, A Guidotti, E Costa, J D Rothstein, M E Goldman, R J Weber, S M Paul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2563854     DOI： 10.1016/s0140-6736(89)91384-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 2.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 3.  Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.

Authors:  J D Rothstein; M Olasmaa
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 4.  Supersensitivity of GABA-A receptors in hepatic encephalopathy.

Authors:  M Baraldi
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 5.  Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy.

Authors:  M Baraldi; R Avallone; L Corsi; I Venturini; C Baraldi; M L Zeneroli
Journal:  Metab Brain Dis       Date:  2008-12-11       Impact factor: 3.584

6.  Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy.

Authors:  R Avallone; M L Zeneroli; I Venturini; L Corsi; P Schreier; M Kleinschnitz; C Ferrarese; F Farina; C Baraldi; N Pecora; M Frigo; M Baraldi
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 7.  Flumazenil in the treatment of portal systemic encephalopathy--an overview.

Authors:  K Gyr; R Meier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

8.  Tissue-specific expression of the diazepam-binding inhibitor in Drosophila melanogaster: cloning, structure, and localization of the gene.

Authors:  M Kolmer; C Roos; M Tirronen; S Myöhänen; H Alho
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  Plasma concentrations of endogenous benzodiazepine-receptor ligands in patients with hepatic encephalopathy: a comparative study.

Authors:  C A Hernández-Avila; W J Shoemaker; H A Ortega-Soto
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

10.  Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo.

Authors:  Mohammad A Esmaeili; Shilpi Yadav; Ravi Kr Gupta; Garrett R Waggoner; Abigail Deloach; Noel Y Calingasan; M Flint Beal; Mahmoud Kiaei
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.